Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
The interplay between antibodies and T cells in HIV risk
From the HVTN and Vaccine and Infectious Disease Division
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
System vaccinology, providing information for the future
From Vaccine and Infectious Disease Division
Dr. Hootie Warren takes helm of Fred Hutch Global Oncology
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
IgG rules HIV mucosal protection
McElrath Laboratory, Vaccine and Infectious Disease Division
With Fred Hutch's HIV lab in South Africa, 'We've become full partners.'
An HIV laboratory in South Africa advances scientific understanding, and more
In Uganda, strengthening a partnership against cancer
A ‘compelling and inspiring visit’ yields renewed commitment by Fred Hutch, Ugandan leaders
Good News at Fred Hutch
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements, and other notable news
Super survivors: What those with HIV who don't get sick can teach us
Meet five ‘HIV controllers,’ some positive for decades, who may hold clues to ending AIDS
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds
Growing a lab: How a young scientist makes leap from postdoc to principal investigator
A young scientist makes the leap from postdoc to principal investigator
Madame Peng Liyuan, first lady of China, visits Fred Hutch
Bill and Melinda Gates, Nobel-winner Dr. Linda Buck among luminaries meeting and touring Hutch HIV vaccine lab
An 'audacious and ambitious' building
Seattle celebrates the opening of the new Uganda-Fred Hutch cancer center
Seattle researchers are a significant step closer to an HIV vaccine
Research team finds a vaccine candidate that stimulates the production of neutralizing antibodies that defend against infection from a broad spectrum of HIV strains
Closing in on ‘holy grail’ of HIV vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies
Leading HIV researcher, other scientists and advocates among those killed in Malaysia Airlines crash
HIV researchers stunned, pledge to continue the mission of those lost
HIV vaccine researcher Julie McElrath receives Women of Influence Award - Fred Hutchinson Cancer Research Center
She is among 16 recipients of annual award sponsored by Puget Sound Business Journal
'This is about survival': Hutch opens Cape Town Lab to move HIV vaccine forward
Ribbon cutting ceremony marks the official opening of the Cape Town Immunology Laboratory
Fred Hutchinson Cancer Research Center opens HIV-vaccine lab in South Africa - Fred Hutchinson Cancer Research Center
Cape Town facility is integral in the effort to stop the global spread of AIDS
Fighting HIV on its own turf
Fred Hutch is opening a Cape Town lab to launch HIV vaccine trials in South Africa, where the virus has infected more people than in any other country